← Back to Search

Regional Anesthesia

Bilateral Erector Spinae Plane Block (ESPB) for Congenital Heart Disease

N/A

Waitlist Available

Led By Thomas Caruso, MD, MEd

Research Sponsored by Stanford University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up duration of postoperative recovery (typically 1-2 weeks)

Awards & highlights

Study Summary

This trial will test whether a new kind of pain relief, called the erector spinae plane block, can help decrease postoperative pain and other complications in high-risk children and adults who have had heart surgery.

Eligible Conditions

Congenital Heart Disease
Congenital Heart Defects
Local Anesthesia
Opioid Use Disorder

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ duration of postoperative recovery (typically 1-2 weeks)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~duration of postoperative recovery (typically 1-2 weeks)

This trial's timeline: 3 weeks for screening, Varies for treatment, and duration of postoperative recovery (typically 1-2 weeks) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Determine average post-operative pain scores in patients with ESPB

Determine opioid consumption

Median Cardiovascular Intensive Care Unit (CVICU) LOS in patients with ESPB

+1 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Erector Spinae Plane BlockExperimental Treatment1 Intervention

All participants will get the Erector Spinae Plane block (ESPB) as a prospective cohort study. After anesthesia induction all enrolled patients will have bilateral ESPB catheters placed at the T7 spine level prior to surgery. The surgery is a sternotomy for congenital heart repair in high risk children and adults.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Bilateral Erector Spinae Plane Block (ESPB)

2019

N/A

~40

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor

2,387 Previous Clinical Trials

17,334,012 Total Patients Enrolled

Thomas Caruso, MD, MEdPrincipal InvestigatorStanford University

Media Library

Bilateral Erector Spinae Plane Block (ESPB) (Regional Anesthesia) Clinical Trial Eligibility Overview. Trial Name: NCT03611374 — N/A

Congenital Heart Disease Research Study Groups: Erector Spinae Plane Block

Congenital Heart Disease Clinical Trial 2023: Bilateral Erector Spinae Plane Block (ESPB) Highlights & Side Effects. Trial Name: NCT03611374 — N/A

Bilateral Erector Spinae Plane Block (ESPB) (Regional Anesthesia) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03611374 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any remaining vacancies on this clinical trial?

"As per the information hosted on clinicaltrials.gov, this medical trial has stopped recruiting patients; having been initially posted on June 7th 2019 and last updated on July 6th 2022. Nonetheless, there are still 520 other trials searching for participants at present."

Answered by AI

What qualifications must a participant possess to take part in this experiment?

"This experiment is open to a total of 50 individuals who have reported opioid use and are aged between 0-99 years old."

Answered by AI

Are there any age restrictions for participants in this study?

"This medical experiment accepts patients between the ages of 0 to 99. Notably, there are 116 trials available for minors and 419 studies open to seniors over 65 years old."

Answered by AI

Recent research and studies

New England Journal of MedicineJournal

Halothane–morphine Compared with High-dose Sufentanil for Anesthesia and Postoperative Analgesia in Neonatal Cardiac Surgery

Anand, K.J.S., and P.R. Hickey. 1992. “Halothane–morphine Compared with High-dose Sufentanil for Anesthesia and Postoperative Analgesia in Neonatal Cardiac Surgery”. New England Journal of Medicine. Massachusetts Medical Society. doi:10.1056/nejm199201023260101.

Journal of Cardiothoracic and Vascular AnesthesiaJournal

Parasternal Intercostal Block with Ropivacaine for Postoperative Analgesia in Pediatric Patients Undergoing Cardiac Surgery: A Double-blind, Randomized, Controlled Study

Chaudhary, Vishal, Sandeep Chauhan, Minati Choudhury, Usha Kiran, Sumit Vasdev, and Sachin Talwar. 2012. “Parasternal Intercostal Block with Ropivacaine for Postoperative Analgesia in Pediatric Patients Undergoing Cardiac Surgery: A Double-blind, Randomized, Controlled Study”. Journal of Cardiothoracic and Vascular Anesthesia. Elsevier BV. doi:10.1053/j.jvca.2011.10.012.

The Journal of Thoracic and Cardiovascular SurgeryJournal

Postoperative Complications and Association with Outcomes in Pediatric Cardiac Surgery

Agarwal, Hemant S., Karen B. Wolfram, Benjamin R. Saville, Brian S. Donahue, and David P. Bichell. 2014. “Postoperative Complications and Association with Outcomes in Pediatric Cardiac Surgery”. The Journal of Thoracic and Cardiovascular Surgery. Elsevier BV. doi:10.1016/j.jtcvs.2013.10.031.

Journal of Clinical AnesthesiaJournal